API / Intermediate Services

Portfolio Management

• 125+ dosage filings in the US, 20+ in Europe and 1400+ in the rest of the world
• Products on the market in key geographies such as US, Germany, Romania, Bulgaria, India, Russia, Ukraine/CIS, Venezuela
• Formulation development team that has expertise in customizing existing products to meet innovator trade-dress requirements if needed
• Big Pharma looking to rationalize portfolio of finished dosages and hence outsource manufacture of mature products, have access to a substantial ready-for-market basket